Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Guinn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Thoracic Disease|September 13, 2024
Safety first: historical lessons on the responsible implementation of artificial intelligenceTravis J Miles, Michael T Guinn, Ravi K Ghanta
The Annals of Thoracic Surgery|December 4, 2025
The Vasoplegia Risk Score: A Key Step Towards Individualized Vasoplegia Risk AssessmentTravis J Miles, Michael T Guinn, Ravi K Ghanta, et al.
Biosensors & Bioelectronics|July 27, 2015
Reconfigurable hybrid interface for molecular marker diagnostics and in-situ reportingKristina Ehrhardt, Michael T Guinn, Tyler Quarton, et al.
JTCVS Open|July 9, 2025
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgeryTravis J Miles, Michael T Guinn, Orlando R Suero, et al.
The Annals of Thoracic Surgery|March 22, 2025
A Novel Clinical Risk Score to Predict Vasoplegia After Adult Cardiac SurgeryTravis J Miles, Michael T Guinn, Orlando R Suero, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Tissue perfusion pressure: A novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgeryTravis J Miles, Michael T Guinn, Xin Tan, et al.
The Journal of Clinical Investigation|June 18, 2024
Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant toleranceTakahiro Yokose, Edward S Szuter, Ivy Rosales, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodiesCody Fell, Anthony E Davis, Shalini Pandey, et al.
Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Thoracic Disease|September 13, 2024
Safety first: historical lessons on the responsible implementation of artificial intelligenceTravis J Miles, Michael T Guinn, Ravi K Ghanta
The Annals of Thoracic Surgery|December 4, 2025
The Vasoplegia Risk Score: A Key Step Towards Individualized Vasoplegia Risk AssessmentTravis J Miles, Michael T Guinn, Ravi K Ghanta, et al.
Biosensors & Bioelectronics|July 27, 2015
Reconfigurable hybrid interface for molecular marker diagnostics and in-situ reportingKristina Ehrhardt, Michael T Guinn, Tyler Quarton, et al.
JTCVS Open|July 9, 2025
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgeryTravis J Miles, Michael T Guinn, Orlando R Suero, et al.
The Annals of Thoracic Surgery|March 22, 2025
A Novel Clinical Risk Score to Predict Vasoplegia After Adult Cardiac SurgeryTravis J Miles, Michael T Guinn, Orlando R Suero, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Tissue perfusion pressure: A novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgeryTravis J Miles, Michael T Guinn, Xin Tan, et al.
The Journal of Clinical Investigation|June 18, 2024
Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant toleranceTakahiro Yokose, Edward S Szuter, Ivy Rosales, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodiesCody Fell, Anthony E Davis, Shalini Pandey, et al.
Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.
Pageof 1